Plasmapp Co., Ltd. is a Korea-based company mainly engaged in the provision of medical solutions. The Company is engaged in the provision of low temperature plasma sterilization solutions, implant regeneration and activation solutions. The Company is also engaged in the manufacture and sale of medical devices. The Company's products include sterilizers, sterile consumables, regenerative activators, consumables, accessories and others.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
21/09/26	KRW 3,330.00	+1.52%	6,207
18/09/26	KRW 3,280.00	-2.67%	10,457
17/09/26	KRW 3,370.00	+0.30%	10,360
16/09/26	KRW 3,360.00	-2.75%	29,060
15/09/26	KRW 3,455.00	+7.30%	12,138

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 21/09/2026			5-day change	1st Jan Change
3,330.00 ^KRW	+1.52%		+3.42%	-42.59%

31/07	Plasmapp Co., Ltd. announced that it has received KRW 7.00000128 billion in funding from DREAMTECH Co., Ltd.	CI
23/07	Plasmapp Co., Ltd. announced that it expects to receive KRW 7.00000128 billion in funding from DREAMTECH Co., Ltd.	CI

Market Cap	12.78B 9.29M 8.1M 7.63M 6.95M 13.03M 890M 13.05M 91.41M 35.23M 454M 34.91M 34.14M 1.46B	P/E 2024	-1.45x	P/E 2025	-3.03x
Enterprise Value	18.1B 13.16M 11.48M 10.81M 9.85M 18.46M 1.26B 18.48M 129M 49.9M 642M 49.45M 48.35M 2.07B	EV / Sales 2024	4.06x	EV / Sales 2025	3.25x
Free-Float	62.37%	Yield 2024 *	-	Yield 2025	-

31/07	Plasmapp Co., Ltd. announced that it has received KRW 7.00000128 billion in funding from DREAMTECH Co., Ltd.	CI
23/07	Plasmapp Co., Ltd. announced that it expects to receive KRW 7.00000128 billion in funding from DREAMTECH Co., Ltd.	CI
04/06	South Korean Shares Close Nearly 2% Lower on Overnight Wall Street Losses, Fresh Middle East Tensions	MT
04/06	Plasmapp Clinches KRW3.5 Billion Supply Contract	MT
31/03	Plasmapp wins 2.5 billion won order	RE
31/03/25	Plasmapp To Conduct Capital Increase Of 7.4 Billion Won	RE
31/03/25	Plasmapp Co., Ltd. announced that it expects to receive KRW 7.3599448 billion in funding from DREAMTECH Co., Ltd., Namuga Co., Ltd. and other investors	CI
29/07/24	Plasmapp Co., Ltd. announced that it has received KRW 15.36492551 billion in funding from DREAMTECH Co., Ltd., Namuga Co., Ltd.	CI
18/07/24	Plasmapp Co., Ltd. announced that it expects to receive KRW 15.36492551 billion in funding from DREAMTECH Co., Ltd., Namuga Co., Ltd.	CI
21/04/24	Plasmapp Co., Ltd. announced that it expects to receive KRW 4.5 billion in funding	CI
21/11/23	AdaptivEndo and Plasmapp Collaborate to Develop Sterilization Techniques for Flexible Endoscopy	CI
28/06/23	Plasmapp Co., Ltd. announced that it has received KRW 5.46494676 billion in funding from C & C Co., Ltd.	CI
21/06/23	Plasmapp to Raise 5.5 Billion Won via Shares Issuance	MT

1 day	+1.52%
1 week	+3.42%
Current month	-7.76%
1 month	-4.86%
3 months	-15.37%
6 months	-59.83%
Current year	-42.59%

Plasmapp Co., Ltd. Stock

Stocks

A405000

KR7405000001

Medical Equipment, Supplies & Distribution

Valuation: Plasmapp Co., Ltd.

Chart: Plasmapp Co., Ltd.

Latest news: Plasmapp Co., Ltd.

Quotes and Performance

Price Extremes

Managers and Directors: Plasmapp Co., Ltd.

Latest insider transactions

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Quotes

1 week	3,210	3,675
1 month	3,030	3,840
Current year	3,030	9,200
1 year	3,030	9,400
3 years	3,030	55,700
5 years	3,030	91,500
10 years	3,030	91,500

Manager	Title	Age	Since
Hyung-Min Kim CEO	Chief Executive Officer	56	13/09/2024
Jeong-Hun Lee PRN	Corporate Officer/Principal	48	28/03/2024
Yu-Bong Lim CEO	Chief Executive Officer	45	01/01/2015

Director	Title	Age	Since
Yu-Bong Lim BRD	Director/Board Member	45	13/03/2024
Hyung-Min Kim BRD	Director/Board Member	56	13/09/2024
Yong-Cheol Kim BRD	Director/Board Member	52	13/09/2024

Date	Insider	Type	Quantity	% Market Cap.
29/1/24	Hyeon-Dong Yeo	Sell	3,000	0.0155%
29/1/24	Gyu-Ho Hwang	Sell	1,428	0.0074%
4/1/24	Hyeon-Dong Yeo	Others	3,000	0.0155%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PLASMAPP CO., LTD.	+1.52%	+3.42%	-61.28%	-93.57%	9.29M
ABBOTT LABORATORIES	+0.36%	-0.11%	-24.30%	+4.09%	178B
MEDTRONIC PLC	-0.41%	-2.19%	-3.50%	+14.03%	117B
CENCORA, INC.	+2.50%	-2.99%	+9.13%	+71.14%	60.39B
BECTON, DICKINSON AND COMPANY	-0.13%	-1.21%	-3.39%	-31.82%	49.22B
HOYA CORPORATION	-0.22%	+0.78%	+10.27%	+47.46%	48.02B
DEXCOM, INC.	-0.20%	+5.30%	+32.20%	+0.10%	33.65B
MEDLINE INC.	+1.01%	-1.93%	-	-	28.04B
WEST PHARMACEUTICAL SERVICES, INC.	-0.15%	+1.85%	+41.96%	-3.34%	25.46B
SARTORIUS STEDIM BIOTECH	+1.29%	+7.58%	+10.58%	-11.05%	22.5B
Average	+0.44%	+0.71%	+1.30%	-0.33%	56.28B
Weighted average by Cap.	+0.27%	-0.14%	-2.76%	+13.19%

	2024	2025
Net sales	10.14B 7.38M 6.43M 6.06M 5.52M 10.34M 707M 10.35M 72.53M 27.96M 360M 27.7M 27.09M 1.16B	8.48B 6.17M 5.38M 5.07M 4.61M 8.65M 591M 8.66M 60.69M 23.39M 301M 23.18M 22.67M 972M
Net income	-20.78B -15.12M -13.18M -12.42M -11.31M -21.2M -1.45B -21.23M -149M -57.31M -738M -56.79M -55.53M -2.38B	-6.59B -4.79M -4.18M -3.93M -3.58M -6.72M -459M -6.73M -47.12M -18.16M -234M -18M -17.6M -755M
Net Debt	6.69B 4.86M 4.24M 3.99M 3.64M 6.82M 466M 6.83M 47.82M 18.43M 237M 18.27M 17.86M 766M	5.32B 3.87M 3.37M 3.18M 2.89M 5.43M 371M 5.43M 38.06M 14.67M 189M 14.54M 14.22M 609M